No items found.
Left chevron

Go Back

Pharmacology

Sulfonylureas (Glyburide, Glipizide): Type 2 Diabetes Pharmacology

Sulfonylureas for type 2 diabetes (T2DM) explained: glipizide vs glyburide, mechanism, dosing pearls, hypoglycemia risk, and clinical use.

Video thumbnail

To view this video, please enable marketing cookies from Cookie Preferences in the footer.

Horizontal dot pattern

Dr. Busti covers one of the most-tested Type 2 diabetes drug classes—sulfonylureas. If you’ve ever mixed up glyburide vs glipizide, worried about hypoglycemia, or wanted a clear “when do I pick this?” framework, this drug class review is for you. In this lecture from This is Why, Dr. Busti will break down Sulfonylureas (Glyburide, Glipizide) step-by-step so you can confidently in the context of treating type 2 diabetes (T2DM).

You’ll learn how to:
- Mechanism of action: how sulfonylureas increase insulin release
- Clinical use: where sulfonylureas still fit in modern Type 2 diabetes management
- Drug comparisons: key differences between glyburide, glipizide, and glimepiride
- Adverse effects: why hypoglycemia risk matters, plus weight gain and common pitfalls
- Safety & patient selection: older adults, renal impairment, missed meals, and other high-risk scenarios

Key drugs covered:
- Glipizide
- Glyburide
- Glimepiride
- (Plus core concepts of oral hypoglycemics, insulin secretagogues, and antidiabetic drugs)

The goal = make medical education easy and clinically relevant.


Chapter Table of Contents
00:00 Sulfonylureas Overview: Why This Class Still Matters in T2DM
01:31 2nd-Gen Agents to Know: Glimepiride, Glipizide, Glyburide
02:00 Indications: Type 2 Diabetes as Diet/Exercise Adjunct
02:14 Net Benefit: Cost-Effective A1C Lowering (and the Tradeoffs)
03:23 Mechanism of Action: Beta-Cell Stimulation → Insulin Secretion
04:07 Why They “Burn Out” Beta Cells: Insulin Resistance & Overwork
05:00 KATP Channel Blockade: Depolarization → Calcium → Insulin Release
06:09 High-Yield Pearl: Glyburide, Renal Clearance & Hypoglycemia Risk
06:50 Where Sulfonylureas Fit in Therapy: Secretagogues vs Newer Agents
10:13 Comorbidities: Why They’re Rarely “Preferred” (Avoid in Obesity)
11:37 Dosing Strategies & Key Contraindications (Type 1, DKA)
14:17 Sulfa Allergy Myth-Busting + Special Pops & Monitoring (Beers List)

If this helped you, please like, subscribe to our YouTube Channel, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.

Don’t forget to turn on notifications on YouTube so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!

#sulfonylureas #type2diabetes #glipizide #glyburide #busti

Disclaimer:
This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

This is why - membership

More than just access—it’s where understanding deepens.

Create a free account or log in to gain access to this content!

Dot pattern graphic

Dive Deeper

Bonus Video (ad free)

Deep Dive video thumbnail

To view this video, please enable marketing cookies.

Downloads

Antidiabetic Agents Lecture Tables

Dive Deeper

Bonus Video

Downloads

Antidiabetic Agents Lecture Tables